Blue Clay Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SNBR
Sleep Number
SNBR
|
+$9.4M |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$3.22M |
| 3 |
JetBlue
JBLU
|
+$1.7M |
| 4 |
Delta Air Lines
DAL
|
+$1.62M |
| 5 |
HIBB
Hibbett, Inc. Common Stock
HIBB
|
+$1.27M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
H.B. Fuller
FUL
|
+$1.52M |
| 2 |
FCRD
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
|
+$1.18M |
| 3 |
Bio-Techne
TECH
|
+$944K |
| 4 |
CTP
CTPARTNERS EXECUTIVE SEARCH INC (DE)
CTP
|
+$891K |
| 5 |
ENZ
Enzo Biochem, Inc.
ENZ
|
+$830K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 34.98% |
| 2 | Industrials | 8.04% |
| 3 | Healthcare | 4.2% |
| 4 | Communication Services | 3.45% |
| 5 | Technology | 2.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
RAVE Restaurant Group
RAVE
$44.6M
| – | – |
-25,000
| Closed | -$178K |
|
|
77
Bio-Techne
TECH
$11.3B
| – | – |
-40,856
| Closed | -$944K |
|
78
UNIFI
UFI
$134M
| – | – |
-13,166
| Closed | -$391K |
|
|
ENZ
79
DELISTED
Enzo Biochem, Inc.
ENZ
| – | – |
-186,900
| Closed | -$830K |
|
|
FCRD
80
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
| – | – |
-100,388
| Closed | -$1.18M |
|
|
JNS
81
DELISTED
Janus Capital Group Inc
JNS
| – | – |
-32,129
| Closed | -$518K |
|
|
ACAT
82
CALL
DELISTED
Arctic Cat Inc
ACAT
| – | – |
-10,000
| Closed | -$355K |
|
|
CTP
83
DELISTED
CTPARTNERS EXECUTIVE SEARCH INC (DE)
CTP
| – | – |
-58,629
| Closed | -$891K |
|
Similar funds
Blue Clay Capital Management's Q1 2015 Portfolio in Review
As of Q1 2015, Blue Clay Capital Management held 83 positions worth $192M, up 40% from $137M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Blue Clay Capital Management deployed $43.8M of net new capital in Q1 2015, opening 12 new positions and adding to 23 existing holdings. Its largest new stake was Alphabet (Google) Class C: 120,329 shares worth $3.3M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 35% of assets, down from 35% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was Ligand Pharmaceuticals, an estimated $302K trimmed.
- Blue Clay Capital Management's largest Q1 2015 buy was Alphabet (Google) Class C: 120,329 shares worth $3.3M.
- Blue Clay Capital Management added most to Sleep Number in Q1 2015, an estimated $9.4M increase.
- Blue Clay Capital Management's biggest Q1 2015 reduction was Ligand Pharmaceuticals, cutting an estimated $302K.
- Blue Clay Capital Management fully exited H.B. Fuller in Q1 2015, selling an estimated $1.52M.
- Blue Clay Capital Management's ten largest holdings make up 63% of its $192M portfolio in Q1 2015.
- Blue Clay Capital Management opened 12 new positions and closed 12 in Q1 2015.
- Blue Clay Capital Management's portfolio value rose 40% quarter-over-quarter to $192M.
Based on Blue Clay Capital Management's 13F filing for Q1 2015, filed 15 May 2015.